Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,484Revenue $M173Net Margin (%)59.6Z-Score30.8
Enterprise Value $M1,249EPS $3.3Operating Margin %68.1F-Score6
P/E(ttm))22.6Cash Flow Per Share $-0.9Pre-tax Margin (%)68.2Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %0Quick Ratio9.2Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %0Current Ratio9.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)90.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)106Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.5ROI % (ttm)-59.8Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKJean-Marie Eveillard 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 52.1035%Add 28.35%1,161,805
NLNKJean-Marie Eveillard 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 52.1066%Add 21.32%778,354
NLNKJean-Marie Eveillard 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 52.1070%Add 95.04%641,554
NLNKJean-Marie Eveillard 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 52.1077%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wiley BrianVP of Business Development 2015-02-17Sell10,000$40.0732.27view
Ramsey William J.Quality Assurance Officer 2015-02-17Sell2,500$4032.5view
Link Charles J. Jr.Chairman of the Board and CEO 2015-02-05Sell20,000$32.4163.53view
Ramsey William J.Quality Assurance Officer 2015-01-23Sell2,500$4032.5view
Link Charles J. Jr.Chairman of the Board and CEO 2015-01-07Sell20,000$37.9939.51view
Wiley BrianVP of Business Development 2015-01-02Sell20,000$40.3331.42view
Link Charles J. Jr.Chairman of the Board and CEO 2014-12-04Sell20,000$37.8440.06view
HENNEMAN JOHN B IIIEVP, CFO 2014-11-25Buy5,000$34.3554.29view
Link Charles J. Jr.Chairman of the Board and CEO 2014-11-10Sell20,000$32.9460.9view
LINK GORDON H JRCFO 2014-10-24Sell2,500$40.3931.22view

Press Releases about NLNK :

    Quarterly/Annual Reports about NLNK:

    News about NLNK:

    Articles On GuruFocus.com
    NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 


    More From Other Websites
    Tekmira Ebola drug succeeds in small monkey study Apr 22 2015
    NewLink Genetics to Host Its First Quarter 2015 Earnings Results Conference Call on May 5, 2015 Apr 21 2015
    NewLink Genetics to Host Its First Quarter 2015 Earnings Results Conference Call on May 5, 2015 Apr 21 2015
    NEWLINK GENETICS CORP Files SEC form 8-K, Other Events Apr 17 2015
    Merck, NewLink Ebola Vaccine Enters Third Phase III Study - Analyst Blog Apr 15 2015
    Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra... Apr 14 2015
    NewLink Genetics and Merck & Co Receives Vaccine Industry Excellence Awards at World Vaccine... Apr 14 2015
    NewLink Genetics to Participate in the Upcoming Needham and Jefferies Conferences Apr 14 2015
    NewLink Genetics and Merck & Co Receives Vaccine Industry Excellence Awards at World Vaccine... Apr 14 2015
    How the Hottest Biotech Sprouted in Iowa Apr 12 2015
    Completing Ebola vaccine trials "a challenge" as epidemic wanes Apr 10 2015
    Completing Ebola vaccine trials "a challenge" as epidemic wanes Apr 10 2015
    NewLink Genetics to Participate in the Upcoming Needham and Jefferies Conferences Apr 07 2015
    Catalysts and Data Could Move 4 Top Biotech Stocks to Buy Apr 06 2015
    Merck, NewLink Ebola vaccine appears safe, effective in new studies Apr 01 2015
    A pair of security-software stocks are in play Mar 31 2015
    NewLink Genetics (NLNK) Shares March Higher, Can It Continue? - Tale of the Tape Mar 31 2015
    The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases Mar 27 2015
    3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News Mar 25 2015
    NEWLINK GENETICS CORP Financials Mar 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK